A Single-Center, Open-Label, Fixed-Sequence Clinical Study to Evaluate the Pharmacokinetic Effects of Supaglutide on Digoxin or Metformin in Healthy Subjects

被引：0
|
作者：
He Jinjie
Zhang Jing
Anwar, Dilbar
Wu Haiya
Wang, Qinghua
Wu, Xiaojie
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-15-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetic Interaction between Maraviroc and Fosamprenavir-Ritonavir: an Open-Label, Fixed-Sequence Study in Healthy Subjects
    Vourvahis, Manoli
    Plotka, Anna
    da Costa, Laure Mendes
    Fang, Annie
    Heera, Jayvant
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 6158 - 6164
  • [2] AN OPEN-LABEL, 2-PERIOD, FIXED-SEQUENCE STUDY TO EVALUATE THE EFFECT OF LOPERAMIDE ON THE PHARMACOKINETICS OF NERATINIB IN HEALTHY SUBJECTS.
    Keyvanjah, K.
    Martin, D.
    Cooke, B.
    Sterling, L.
    Liang, J.
    Olek, E.
    Rubets, I.
    Wong, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S73 - S73
  • [3] The Effects of Boceprevir and Telaprevir on the Pharmacokinetics of Maraviroc: An Open-Label, Fixed-Sequence Study in Healthy Volunteers
    Vourvahis, Manoli
    Plotka, Anna
    Kantaridis, Constantino
    Fang, Annie
    Heera, Jayvant
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (05) : 564 - 570
  • [4] A PHASE 1 OPEN-LABEL, FIXED-SEQUENCE 3-PERIOD STUDY TO EVALUATE PHARMACOKINETIC INTERACTIONS BETWEEN FIMASARTAN AND INDAPAMIDE IN HEALTHY VOLUNTEERS
    Shin, W.
    Yang, A.
    Yoo, H.
    Kim, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S78 - S78
  • [5] Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover Study
    Huang, Fenglei
    Voelk, Claudia
    Trampisch, Matthias
    Rowland, Lois
    Schultz, Armin
    Sabo, John P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (01) : 84 - 93
  • [6] Pharmacokinetics of Sugammadex: An Open-Label, 3-Period, Fixed-Sequence, 3-Single-Doses Study in Healthy Chinese Subjects
    Yuan, Fei
    Yang, Mengjie
    Chen, Weili
    Chen, Hanjing
    Xu, Hongrong
    Li, Hui
    Sheng, Lei
    Li, Xuening
    Ellen Wrishko, Rebecca
    Joel Woolf, Eric
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (03): : 333 - 340
  • [7] Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: A single-center, multiple-dose, open-label study
    Rao, N
    Chou, T
    Ventura, D
    Abramowitz, W
    CLINICAL THERAPEUTICS, 2005, 27 (10) : 1596 - 1606
  • [8] Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single-center, open-label phase I trial
    Deng, Kunhong
    Zou, Yi
    Zou, Chan
    Wang, Hong
    Xiang, Yuxia
    Yang, Xiaoyan
    Yang, Shuang
    Cui, Chang
    Yang, Guoping
    Huang, Jie
    CANCER MEDICINE, 2023, 12 (02): : 1431 - 1440
  • [9] AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF SOTORASIB (AMG 510) ON DIGOXIN PHARMACOKINETICS IN HEALTHY SUBJECTS.
    Cardona, P.
    Spring, M.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S80 - S80
  • [10] AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF SOTORASIB (AMG 510) ON DIGOXIN PHARMACOKINETICS IN HEALTHY SUBJECTS.
    Cardona, P.
    Spring, M.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S31 - S31
12345